{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:47:58Z","timestamp":1762004878758},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1097\/md.0000000000006887","type":"journal-article","created":{"date-parts":[[2017,5,10]],"date-time":"2017-05-10T13:25:21Z","timestamp":1494422721000},"page":"e6887","source":"Crossref","is-referenced-by-count":11,"title":["A selective screening program for the early detection of mucopolysaccharidosis"],"prefix":"10.1097","volume":"96","author":[{"given":"Crist\u00f3bal","family":"Col\u00f3n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Victor","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Casta\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu\u00eds G.","family":"Gutierrez-Solana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana M.","family":"Marquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"O\u2019Callaghan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e9lix","family":"S\u00e1nchez-Valverde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Yeste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda-Luz","family":"Couce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-60-20210226","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/adc.72.3.263","article-title":"The mucopolysaccharidoses: a clinical review and guide to management","volume":"72","author":"Wraith","year":"1995","journal-title":"Arch Dis Child"},{"key":"R2-60-20210226","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ymgme.2013.06.007","article-title":"Newborn screening and diagnosis of mucopolysaccharidoses","volume":"110","author":"Tomatsu","year":"2013","journal-title":"Mol Genet Metab"},{"key":"R3-60-20210226","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10545-012-9572-0","article-title":"Behavioural phenotypes of the mucopolysaccharide disorders: a systematic literature review of cognitive, motor, social, linguistic and behavioural presentation in the MPS disorders","volume":"36","author":"Cross","year":"2013","journal-title":"J Inherit Metab Dis"},{"key":"R4-60-20210226","doi-asserted-by":"crossref","first-page":"26","DOI":"10.12968\/bjon.2016.25.1.22","article-title":"Management of the behavioral manifestations of Hunter syndrome","volume":"25","author":"Roberts","year":"2016","journal-title":"Br J Nurs"},{"key":"R5-60-20210226","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2174\/138920111795542615","article-title":"Mucopolysaccharidosis type IVA (Morquio A disease): clinical review and current treatment","volume":"12","author":"Tomatsu","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"key":"R6-60-20210226","first-page":"S142","article-title":"Review of mucopolysaccharidosis diseases at the Queen Sirikit National Institute of Child Health in the past 15 years","volume":"97","author":"Kuptanon","year":"2014","journal-title":"J Med Assoc Thai"},{"key":"R7-60-20210226","first-page":"245","article-title":"Diagnostic and treatment strategies in mucopolysaccharidosis VI","volume":"8","author":"Vairo","year":"2015","journal-title":"Appl Clin Genet"},{"key":"R8-60-20210226","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1016\/j.jcjo.2013.04.010","article-title":"The great masquerade: delayed diagnosis of mucopolysaccharidosis in adulthood","volume":"48","author":"Kurniawan","year":"2013","journal-title":"Can J Ophthalmol"},{"key":"R9-60-20210226","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13052-014-0097-z","article-title":"From hypertransaminasemia to mucopolysaccharidosis IIIA","volume":"40","author":"Krawiec","year":"2014","journal-title":"Ital J Pediatr"},{"key":"R10-60-20210226","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/1750-1172-8-189","article-title":"Natural history of Sanfilippo syndrome in Spain","volume":"8","author":"Delgadillo","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"R11-60-20210226","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ymgmr.2015.03.011","article-title":"Enzymatic replacement therapy for Hunter disease: Up to 9 years, experience with 17 patients","volume":"3","author":"Parini","year":"2015","journal-title":"Mol Genet Metab Rep"},{"key":"R12-60-20210226","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/B978-0-444-59565-2.00055-1","article-title":"Enzyme replacement therapy and substrate reduction therapy in lysosomal storage disorders with neurological expression","volume":"113","author":"Valayannopoulos","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"R13-60-20210226","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jpeds.2004.03.018","article-title":"Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)","volume":"144","author":"Harmatz","year":"2004","journal-title":"J Pediatr"},{"key":"R14-60-20210226","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2165\/00003495-200767180-00005","article-title":"Treatment of lysosomal storage disorders: progress with enzyme replacement therapy","volume":"67","author":"Rohrbach","year":"2007","journal-title":"Drugs"},{"key":"R15-60-20210226","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s10545-014-9715-6","article-title":"Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study","volume":"37","author":"Hendriksz","year":"2014","journal-title":"J Inherit Metab Dis"},{"key":"R16-60-20210226","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1371\/journal.pone.0007434","article-title":"Protein misfolding as an underlying molecular defect in Mucopolysaccharidosis III type C","volume":"4","author":"Feldhammer","year":"2009","journal-title":"PLoS One"},{"key":"R17-60-20210226","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.ymthe.2016.12.025","article-title":"Near-complete correction of profound metabolomic impairments corresponding to functional benefit in MPS IIIB mice after IV rAAV9-hNAGLU gene delivery","volume":"25","author":"Fu","year":"2017","journal-title":"Mol Ther"},{"key":"R18-60-20210226","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/8904_2013_270","article-title":"Aminoglycoside-induced premature stop codon read-through of mucopolysaccharidosis type I patient Q70X and W402X mutations in cultured cells","volume":"13","author":"Kamei","year":"2014","journal-title":"JIMD Rep"},{"key":"R19-60-20210226","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13023-016-0521-0","article-title":"Parents\u2019 experiences of living with, and caring for children, adolescents and young adults with mucopolysaccharidosis (MPS)","volume":"11","author":"Somanadhan","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"R20-60-20210226","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.rchipe.2015.10.004","article-title":"Mucopolysaccharidosis: clinical features, diagnosis and management","volume":"87","author":"Suarez-Guerrero","year":"2016","journal-title":"Rev Chil Pediatr"},{"key":"R21-60-20210226","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1055\/s-0036-1593843","article-title":"Newborn screening for lysosomal storage disorders","volume":"6","author":"Peake","year":"2017","journal-title":"J Pediatr Genet"},{"key":"R22-60-20210226","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cccn.2004.03.015","article-title":"Evaluation of reliability for urine mucopolysaccharidosis screening by dimethylmethylene blue and Berry spot tests","volume":"345","author":"Mabe","year":"2004","journal-title":"Clin Chim Acta"},{"key":"R23-60-20210226","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1515\/cclm-2012-0471","article-title":"Performance of different screening methods for the determination of urinary glycosaminoclycans","volume":"51","author":"Afyoncu","year":"2013","journal-title":"Clin Chem Lab Med"},{"key":"R24-60-20210226","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1093\/clinchem\/47.12.2098","article-title":"Hurler-like phenotype: enzymatic diagnosis in dried blood spots on filter paper","volume":"47","author":"Chamoles","year":"2001","journal-title":"Clin Chem"},{"key":"R25-60-20210226","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jpeds.2014.09.023","article-title":"Lysosomal storage disorder screening implementation: findings from the first six months of full population pilot testing in Missouri","volume":"166","author":"Hopkins","year":"2015","journal-title":"J Pediatr"},{"key":"R26-60-20210226","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1373\/clinchem.2011.164640","article-title":"Simplified newborn screening protocol for lysosomal storage disorders","volume":"57","author":"Metz","year":"2011","journal-title":"Clin Chem"},{"key":"R27-60-20210226","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1053\/j.semperi.2015.03.005","article-title":"Newborn screening for lysosomal storage disorders","volume":"39","author":"Matern","year":"2015","journal-title":"Semin Perinatol"},{"key":"R28-60-20210226","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cca.2016.11.015","article-title":"Screening for mucopolysaccharidoses in the Turkish population: analytical and clinical performance of an age-range specific, dye-based, urinary glycosaminoglycan assay","volume":"464","author":"El Moustafa","year":"2017","journal-title":"Clin Chim Acta"},{"key":"R29-60-20210226","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ymgme.2016.09.005","article-title":"Glycosaminoglycans detection methods: applications of mass spectrometry","volume":"120","author":"Kubaski","year":"2017","journal-title":"Mol Genet Metab"},{"key":"R30-60-20210226","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10545-016-9981-6","article-title":"Newborn screening for mucopolysaccharidoses: a pilot study of measurement of glycosaminoglycans by tandem mass spectrometry","volume":"40","author":"Kubaski","year":"2017","journal-title":"J Inherit Metab Dis"},{"key":"R31-60-20210226","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cca.2014.02.022","article-title":"Correlation of the levels of glycosaminoglycans between urine and dried urine in filter paper samples and their stability over time under different storage temperatures","volume":"433","author":"Breier","year":"2014","journal-title":"Clin Chim Acta"},{"key":"R32-60-20210226","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4155\/bio.15.239","article-title":"Evaluation of urinary keratan sulfate disaccharides in MPS IVA patients using UPLC-MS\/MS","volume":"8","author":"Auray-Blais","year":"2016","journal-title":"Bioanalysis"},{"key":"R33-60-20210226","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1203\/01.PDR.0000113767.60140.E9","article-title":"Development and testing of new screening method for keratan sulfate in mucopolysaccharidosis IVA","volume":"55","author":"Tomatsu","year":"2004","journal-title":"Pediatr Res"},{"key":"R34-60-20210226","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10545-005-5673-3","article-title":"Keratan sulphate levels in mucopolysaccharidoses and mucolipidoses","volume":"28","author":"Tomatsu","year":"2005","journal-title":"J Inherit Metab Dis"},{"key":"R35-60-20210226","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1515\/CCLM.2005.158","article-title":"Alterations of glycosaminoglycan metabolism in the development of diabetic complications in relation to metabolic control","volume":"43","author":"Komosi\u0144ska-Vassev","year":"2005","journal-title":"Clin Chem Lab Med"},{"key":"R36-60-20210226","first-page":"S63","article-title":"Enzyme replacement therapy for the management of the mucopolysaccharidoses","volume":"47","author":"Wraith","year":"2009","journal-title":"Int J Clin Pharmacol Ther"},{"key":"R37-60-20210226","first-page":"e1","article-title":"Clinical practice guideline for the management of Hunter syndrome. Hunter Espa\u00f1a working group","volume":"141","author":"Guill\u00e9n-Navarro","year":"2013","journal-title":"Med Clin (Barc"},{"key":"R38-60-20210226","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ymgme.2015.12.157","article-title":"Implementing evidence-driven individualized treatment plans within Morquio A Syndrome","volume":"117","author":"Clarke","year":"2016","journal-title":"Mol Genet Metab"},{"key":"R39-60-20210226","first-page":"CD009806","article-title":"Enzyme replacement therapy with galsulfase for mucopolysaccharidosis type VI","volume":"3","author":"Brunelli","year":"2016","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000006887","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:49:40Z","timestamp":1620960580000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201705120-00060"}},"subtitle":["Results of the FIND project \u2013 a 2-year follow-up study"],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":39,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000006887","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]}}}